======= KIAA0947 ======= == Gene Information == * **Official Symbol**: ICE1 * **Official Name**: interactor of little elongation complex ELL subunit 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=23379|23379]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9Y2F5|Q9Y2F5]] * **Interactions**: [[https://thebiogrid.org/search.php?search=KIAA0947&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20KIAA0947|Open PubMed]] * **OMIM**: [[https://omim.org/entry/617958|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Component of the little elongation complex (LEC), a complex required to regulate small nuclear RNA (snRNA) gene transcription by RNA polymerase II and III (PubMed:22195968, PubMed:23932780). Specifically acts as a scaffold protein that promotes the LEC complex formation and recruitment and RNA polymerase II occupancy at snRNA genes in subnuclear bodies (PubMed:23932780). {ECO:0000269|PubMed:22195968, ECO:0000269|PubMed:23932780}. No Pfam Domain information is available for this gene. |histone locus body| |snRNA transcription by RNA polymerase III| |positive regulation of transcription by RNA polymerase III| |regulation of transcription by RNA polymerase III| |transcriptionally active chromatin| |transcription elongation factor complex| |transcription by RNA polymerase III| |Cajal body| |snRNA transcription by RNA polymerase II| |snRNA transcription| |ncRNA transcription| |positive regulation of intracellular protein transport| |positive regulation of intracellular transport| |regulation of intracellular protein transport| |positive regulation of protein complex assembly| |nuclear body| |positive regulation of cellular protein localization| |regulation of intracellular transport| |positive regulation of protein transport| |regulation of protein complex assembly| |positive regulation of establishment of protein localization| |transcription by RNA polymerase II| |positive regulation of cellular component biogenesis| |regulation of cellular protein localization| |transcription, DNA-templated| |nucleic acid-templated transcription| |RNA biosynthetic process| |regulation of protein transport| |regulation of peptide transport| |regulation of establishment of protein localization| |protein homodimerization activity| |regulation of cellular localization| |regulation of cellular component biogenesis| |positive regulation of transport| |regulation of protein localization| |nucleobase-containing compound biosynthetic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |positive regulation of cellular component organization| |organic cyclic compound biosynthetic process| |positive regulation of transcription, DNA-templated| |cellular nitrogen compound biosynthetic process| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |RNA metabolic process| |cellular macromolecule biosynthetic process| |positive regulation of RNA metabolic process| |macromolecule biosynthetic process| |regulation of transport| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp412|THZ531 0.11 to 0.125 to 0.35μM on day4 then day6 R07 exp412]]|1.73| |[[:results:exp51|Nifuroxazide 1μM R01 exp51]]|1.76| |[[:results:exp54|Taxol 0.002μM R01 exp54]]|1.77| |[[:results:exp326|CCT251545 20μM R07 exp326]]|1.83| |[[:results:exp351|Dexamethasone 0.006μM R07 exp351]]|1.85| |[[:results:exp40|2-Methoxyestradiol 0.2μM R01 exp40]]|1.9| |[[:results:exp389|PF-06409577 20μM R07 exp389]]|1.91| |[[:results:exp476|Dihydrosphingosine 8μM R08 exp476]]|2.06| |[[:results:exp410|THZ531 0.11 to 0.125μM on day4 R07 exp410]]|2.26| |[[:results:exp155|UNC1999 2μM R03 exp155]]|2.31| |[[:results:exp409|THZ531 0.11μM R07 exp409]]|2.77| ^Gene^Correlation^ |[[:human genes:r:rpl35|RPL35]]|0.518| |[[:human genes:c:chd4|CHD4]]|0.498| |[[:human genes:s:sf3a3|SF3A3]]|0.489| |[[:human genes:p:psmb4|PSMB4]]|0.482| |[[:human genes:g:golga6l1|GOLGA6L1]]|0.477| |[[:human genes:t:tceb3cl2|TCEB3CL2]]|0.474| |[[:human genes:t:tceb3c|TCEB3C]]|0.473| |[[:human genes:v:vasn|VASN]]|0.464| |[[:human genes:c:c1qtnf9b|C1QTNF9B]]|0.459| |[[:human genes:p:psmd2|PSMD2]]|0.453| |[[:human genes:i:ints5|INTS5]]|0.449| |[[:human genes:n:nol10|NOL10]]|0.449| |[[:human genes:w:wdr75|WDR75]]|0.448| |[[:human genes:r:rpl6|RPL6]]|0.448| |[[:human genes:t:tceb3cl|TCEB3CL]]|0.445| |[[:human genes:b:brd2|BRD2]]|0.444| |[[:human genes:t:ticrr|TICRR]]|0.444| |[[:human genes:t:twistnb|TWISTNB]]|0.439| |[[:human genes:p:psma7|PSMA7]]|0.436| |[[:human genes:r:rps9|RPS9]]|0.434| |[[:human genes:p:prim1|PRIM1]]|0.434| |[[:human genes:c:c14orf93|C14orf93]]|0.431| |[[:human genes:c:cgb2|CGB2]]|0.431| |[[:human genes:h:hist2h3a|HIST2H3A]]|0.429| |[[:human genes:c:cope|COPE]]|0.429| |[[:human genes:e:exosc9|EXOSC9]]|0.428| |[[:human genes:h:hist2h3c|HIST2H3C]]|0.428| |[[:human genes:s:sf3b2|SF3B2]]|0.425| |[[:human genes:c:ctage4|CTAGE4]]|0.424| |[[:human genes:p:psma6|PSMA6]]|0.422| |[[:human genes:r:rps2|RPS2]]|0.419| |[[:human genes:r:rps5|RPS5]]|0.417| |[[:human genes:p:pole|POLE]]|0.416| |[[:human genes:r:rpl15|RPL15]]|0.415| |[[:human genes:c:cacna1a|CACNA1A]]|0.413| |[[:human genes:n:nup160|NUP160]]|0.411| |[[:human genes:r:rps3a|RPS3A]]|0.411| |[[:human genes:a:akirin2|AKIRIN2]]|0.411| |[[:human genes:o:orc1|ORC1]]|0.409| |[[:human genes:p:psmb2|PSMB2]]|0.409| |[[:human genes:r:rps16|RPS16]]|0.409| |[[:human genes:k:kctd17|KCTD17]]|0.409| |[[:human genes:r:rpl30|RPL30]]|0.408| |[[:human genes:p:pola1|POLA1]]|0.405| |[[:human genes:g:golga6l3|GOLGA6L3]]|0.404| |[[:human genes:r:rnf113a|RNF113A]]|0.403| |[[:human genes:n:nelfcd|NELFCD]]|0.403| |[[:human genes:r:rps10|RPS10]]|0.403| |[[:human genes:s:slc6a17|SLC6A17]]|0.403| |[[:human genes:n:npipb5|NPIPB5]]|0.401| |[[:human genes:t:tspy2|TSPY2]]|0.4| |[[:human genes:m:mfsd12|MFSD12]]|0.4| Global Fraction of Cell Lines Where Essential: 110/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|0/1| |bile duct|3/28| |blood|3/28| |bone|5/26| |breast|8/33| |central nervous system|5/56| |cervix|0/4| |colorectal|1/17| |esophagus|1/13| |fibroblast|0/1| |gastric|0/16| |kidney|5/21| |liver|4/20| |lung|10/75| |lymphocyte|5/16| |ovary|8/26| |pancreas|2/24| |peripheral nervous system|3/16| |plasma cell|3/15| |prostate|1/1| |skin|3/24| |soft tissue|2/9| |thyroid|0/2| |upper aerodigestive|3/22| |urinary tract|2/29| |uterus|2/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1600 * **Expression level (log2 read counts)**: 7.43 {{:chemogenomics:nalm6 dist.png?nolink |}}